Skip to main content

Advertisement

Log in

External Validation of the Platelet Count/Spleen Diameter Ratio for the Diagnosis of Esophageal Varices in Hepatitis C Virus-Related Cirrhosis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background Screening for esophageal varices (EV) is an important part of the diagnostic workup of cirrhotic patients. Aims To independently validate the use of the platelet count/spleen diameter ratio for the non-invasive diagnosis of EV in patients with HCV-related cirrhosis and in a sub-group of patients with compensated disease. Methods A platelet count/spleen diameter ratio cut-off value of 909 was evaluated for the diagnosis of EV in the whole population (n = 311) and in patients with compensated disease alone (n = 114). Compensated disease was defined as the absence of ascites as detected by abdominal ultrasound in patients who are not on diuretics and absence of hepatic encephalopathy. Results In the whole cohort (EV prevalence 49.5%), the platelet count/spleen diameter ratio 909 cut-off value had 96.9% positive predictive value, 100% negative predictive value, and 98.4% efficiency for EV diagnosis. In compensated cirrhotics (EV prevalence 26.3%), the platelet count/spleen diameter ratio 909 cut-off showed an excellent negative predictive value (100%) and a positive predictive value of 93.8%. for the diagnosis of EV. Conclusions In patients with HCV-related cirrhosis, the platelet count/spleen diameter may be proposed as a non-invasive tool for EV diagnosis, especially in financially deprived developing countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hepatitis C (1997) Global prevalence. Wkly Epidemiol Rec 72:341–344

  2. Sahara AI, Hunt CM, Hamilton JD (1996) Hepatitis C. Ann Intern Med 125:658–668

    Google Scholar 

  3. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P et al (1997) Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112:463–472. doi:10.1053/gast.1997.v112.pm9024300

    Article  PubMed  CAS  Google Scholar 

  4. Gentilini P, Laffi G, La Villa G, Romanelli RG, Buzzelli G, Casini-Raggi V et al (1997) Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 92:66–72

    PubMed  CAS  Google Scholar 

  5. No Authors listed (1998) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 319:983–989

    Google Scholar 

  6. D’Amico G, Pagliaro L, Bosch J (1995) The treatment of portal hypertension: a meta-analytic review. Hepatology 22:332–354. doi:10.1002/hep.1840220145

    PubMed  CAS  Google Scholar 

  7. Rukhsana JF, Javed IF, Masood R, Hameed A, Farooq A, Sultan G (2005) Outcome after injection sclerotherapy for esophageal variceal bleeding in patients with liver cirrhosis and COPD. J Postgrad Med Inst 19:76–80

    Google Scholar 

  8. Salerno F, Borroni G, Moser P, Sangiovanni A, Almasio P, Budillon G et al (1996) Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. J Hepatol 25:474–480. doi:10.1016/S0168-8278(96)80206-6

    Article  PubMed  CAS  Google Scholar 

  9. de Franchis R (2005) Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43:167–176. doi:10.1016/j.jhep. 2005.05.009

    Article  PubMed  Google Scholar 

  10. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology (2007) Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 102:2086–2102. Erratum in Am J Gastroenterol 102:2868. doi:10.1111/j.1572-0241.2007.01681.x

    Google Scholar 

  11. Spiegel BM, Targownik L, Dulai GS, Gralnek IM (2003) Endoscopic screening for esophageal varices in cirrhosis. Is it ever cost effective? Hepatology 37:366–377. doi:doi:10.1053/jhep.2003.50050

    Article  PubMed  Google Scholar 

  12. Arguedas MR, Heudebert GR, Eloubeidi MA, Abrams GA, Fallon MB (2002) Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol 97:2441–2452. doi:10.1111/j.1572-0241.2002.06000.x

    Article  PubMed  Google Scholar 

  13. Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, Cavallarin G, Bolognesi M, Donada C, Bellini B, Torboli P, Gatta A, Gruppo Triveneto per l’Ipertensione Portale (2004) A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology. 127:476–484. doi:10.1053/j.gastro.2004.05.004

    Article  PubMed  CAS  Google Scholar 

  14. Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM et al (1999) Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 94:3285–3291. doi:10.1111/j.1572-0241.1999.1539_a.x

    Article  PubMed  CAS  Google Scholar 

  15. Zaman A, Becker T, Lapidus J, Benner K (2001) Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med 161:2564–2570. doi:10.1001/archinte.161.21.2564

    Article  PubMed  CAS  Google Scholar 

  16. Madhotra R, Mulcahy HE, Willner I, Reuben A (2002) Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 34:81–85. doi:10.1097/00004836-200201000-00016

    Article  PubMed  CAS  Google Scholar 

  17. Levy C, Zein CO, Gomez J, Soldevila-Pico C, Firpi R, Morelli G et al (2007) Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 5:803–808. doi:10.1016/j.cgh.2007.02.031

    Article  PubMed  Google Scholar 

  18. Giannini E, Botta F, Borro P, Malfatti F, Fumagalli A, Testa E et al (2003) Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol 98:2516–2520. doi:10.1111/j.1572-0241.2003.08665.x

    Article  PubMed  CAS  Google Scholar 

  19. Giannini EG (2006) Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther 23:1055–1065. doi:10.1111/j.1365-2036.2006.02889.x

    Article  PubMed  CAS  Google Scholar 

  20. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A et al (2003) Platelet count spleen/diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 52:1200–1205. doi:10.1136/gut.52.8.1200

    Article  PubMed  CAS  Google Scholar 

  21. Giannini EG, Botta F, Borro P, Dulbecco P, Testa E, Mansi C et al (2005) Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up. Dig Liver Dis 37:779–785. doi:10.1016/j.dld.2005.05.007

    Article  PubMed  CAS  Google Scholar 

  22. Zimbwa TA, Blanshard C, Subramaniam A (2004) Platelet count/spleen diameter ratio as a predictor of oesophageal varices in alcoholic cirrhosis. Gut 53:1055

    PubMed  CAS  Google Scholar 

  23. Plestina S, Pulanic R, Kralik M, Plestina S, Samarzija M (2005) Color Doppler ultrasonography is reliable in assessing the risk of esophageal variceal bleeding in patients with liver cirrhosis. Wien Klin Wochenschr 117:711–717. doi:10.1007/s00508-005-0424-x

    Article  PubMed  Google Scholar 

  24. Jeon SW, Cho CM, Tak WY, Ryeom HK, Kweon YO, Kim SK et al (2006) The value of Doppler-ultrasonography and laboratory tests as non-invasive predictors of the presence of esophageal varices in patients with chronic liver disease. Korean J Gastroenterol 48:180–187

    PubMed  Google Scholar 

  25. Kazemi F, Kettaneh A, N’kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, Beaugrand M (2006) Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 45:230–235. doi:10.1016/j.jhep. 2006.04.006

    Article  PubMed  Google Scholar 

  26. Alempijevic T, Bulat V, Djuranovic S, Kovacevic N, Jesic R, Tomic D et al (2007) Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension. World J Gastroenterol 13:5331–5335

    PubMed  Google Scholar 

  27. Justice AC, Covinsky KE, Berlin JA (1999) Assessing the generalizability of prognostic information. Ann Intern Med 130:515–524

    PubMed  CAS  Google Scholar 

  28. Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E et al (2006) Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 101:2511–2519. doi:10.1111/j.1572-0241.2006.00401_6.x

    Article  PubMed  Google Scholar 

  29. Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W et al (1992) Definitions, methodology and therapeutic strategies in portal hypertension. a consensus development workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 15:256–261. doi:10.1016/0168-8278(92)90044-P

    Article  PubMed  Google Scholar 

  30. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–664. doi:10.1002/bjs.1800600817

    Article  PubMed  CAS  Google Scholar 

  31. Kamath PS, Kim WR; Advanced Liver Disease Study Group (2007) The model for end-stage liver disease (MELD). Hepatology 45:797–805. doi:10.1002/hep.21563

    Article  PubMed  Google Scholar 

  32. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561–77

    PubMed  CAS  Google Scholar 

  33. Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J et al (1994) Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol 21:656–666. doi:10.1016/S0168-8278(94)80115-0

    Article  PubMed  CAS  Google Scholar 

  34. Giannini EG, Risso D, Testa R, Trevisani F, Di Nolfo MA, Del Poggio P, Benvegnù L, Ludovico Rapaccini G, Farinati F, Zoli M, Borzio F, Caturelli E, Italian Liver Cancer (ITA.LI.CA.) Group (2006) Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 4:1378–1384. doi:10.1016/j.cgh.2006.08.011

    Article  PubMed  Google Scholar 

  35. Khokhar N, Gill ML, Malik GJ (2004) General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 14:534–536

    PubMed  Google Scholar 

  36. Bukhtiari N, Hussain T, Iqbal M, Malik AM, Qureshi AH, Hussain A (2003) Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc 53:136–140

    PubMed  CAS  Google Scholar 

  37. Ahmad K (2004) Pakistan: a cirrhotic state? Lancet 364:1843–1844. doi:10.1016/S0140-6736(04)17458-8

    Article  PubMed  Google Scholar 

  38. Jensen DM (2002) Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 122:1620–1630. doi:10.1053/gast.2002.33419

    Article  PubMed  Google Scholar 

  39. Giannini EG, Botta F, Testa R (2004) Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone. Gut 53:914–915

    Google Scholar 

  40. Thabut D, Trabut JB, Massard J, Rudler M, Muntenau M, Messous D et al (2006) Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study. Liver Int 26:271–278. doi:10.1111/j.1478-3231.2005.01227.x

    Article  PubMed  Google Scholar 

  41. Eisen GM, Eliakim R, Zaman A, Schwartz J, Faigel D, Rondonotti E et al (2006) The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three-center pilot study. Endoscopy 38:31–35. doi:10.1055/s-2005-921189

    Article  PubMed  CAS  Google Scholar 

  42. Talwalkar JA, Kamath PS (2001) Screening for esophageal varices among patients with cirrhosis of the liver. Am J Gastroenterol 96:3039–3040. doi:10.1111/j.1572-0241.2001.04692.x

    Article  PubMed  CAS  Google Scholar 

  43. Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A (2007) Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc 65:82–88. doi:10.1016/j.gie.2006.08.023

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Professor Jayant A. Talwalkar, M.D., M.P.H., for his helpful suggestions and critical revision of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edoardo G. Giannini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agha, A., Anwar, E., Bashir, K. et al. External Validation of the Platelet Count/Spleen Diameter Ratio for the Diagnosis of Esophageal Varices in Hepatitis C Virus-Related Cirrhosis. Dig Dis Sci 54, 654–660 (2009). https://doi.org/10.1007/s10620-008-0367-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0367-y

Keywords

Navigation